CD4 and COVID-19: A better understanding of SARS-CoV-2 T-cell and antibody adaptive responses prompted further investigation, leading to the measurement of SARS-CoV-2 immunity while identifying epitope pools detecting CD4+ in 100% and CD8+ T cells in 70% of convalescent COVID-19 patients.